Merus NV News - MRUS

Company Name	Stock Ticker Symbol	Market	Type
Merus NV	MRUS	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	40.47	07:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				40.47

more quote information »

Recent News

Date	Time	Source	Heading
4/08/2024	12:00	GLOBE	Merus Presents Preclinical Data Demonstrating Efficacy of..
4/03/2024	08:00	GLOBE	Merus to Participate in a Fireside Chat at the 23rd Annual..
3/06/2024	08:15	EDGAR2	Form 8-K - Current report
3/06/2024	08:00	BW	Gilead and Merus Announce Collaboration to Discover Novel..
3/05/2024	16:30	GLOBE	Merus Announces Publication of an Abstract for Presentation..
3/04/2024	08:00	GLOBE	Merus to Participate in a Fireside Chat at the Leerink..
2/28/2024	16:55	EDGAR2	Form S-3ASR - Automatic shelf registration statement of..
2/28/2024	16:15	GLOBE	Merus Announces Financial Results for the Fourth Quarter and..
2/14/2024	16:05	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/31/2024	08:00	GLOBE	Merus to Participate in Upcoming Investor Conferences
12/20/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/18/2023	17:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	19:29	EDGAR2	Form 144 - Report of proposed sale of securities
12/12/2023	16:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/04/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/02/2023	20:40	GLOBE	Merus Presents Interim Data on MCLA-129 at ESMO Asia..
12/01/2023	10:47	EDGAR2	Form 144 - Report of proposed sale of securities
11/26/2023	11:05	GLOBE	Merus Announces Publication of Abstracts on MCLA-129 for..
11/02/2023	16:12	GLOBE	Merus Announces Financial Results for the Third Quarter 2023..
11/02/2023	16:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/01/2023	08:00	GLOBE	Merus to Participate in Upcoming Investor Conferences
10/23/2023	07:30	GLOBE	Merus’ Zeno Interim Data Continues to Demonstrate Robust and..
10/15/2023	19:58	GLOBE	Merus Announces Business Update Conference Call
10/11/2023	16:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/11/2023	16:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/06/2023	09:32	GLOBE	Merus Announces Abstracts Accepted for Presentation at the..
8/31/2023	08:00	GLOBE	Merus to Participate in Upcoming Investor Conferences
8/11/2023	16:01	EDGAR2	Form 8-K - Current report
8/11/2023	09:00	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
8/09/2023	21:53	GLOBE	Merus Announces Pricing of Public Offering of Common Shares
8/09/2023	16:07	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
8/09/2023	16:01	GLOBE	Merus N.V. Announces Proposed Public Offering of Common..
8/07/2023	16:26	GLOBE	Merus Announces Financial Results for the Second Quarter..
8/07/2023	16:13	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/28/2023	08:00	GLOBE	Merus Announces Two Clinical Abstracts on Zenocutuzumab..
7/05/2023	16:01	GLOBE	Zenocutuzumab (Zeno) granted second Breakthrough Therapy..
6/29/2023	16:30	GLOBE	Zenocutuzumab (Zeno) granted Breakthrough Therapy..
6/15/2023	07:47	GLOBE	Merus Appoints Life Sciences Strategic and Financial..
5/31/2023	08:00	GLOBE	Merus to Participate in a Fireside Chat at the Jefferies..
5/04/2023	16:25	GLOBE	Merus Announces Financial Results for the First Quarter 2023..